APOE and COVID-19: Recently, a study conducted with the UK Biobank (UKB) community cohort, has revealed that ApoE, specifically the ε4∗ε4 genotype, increases the risk of severe Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [13].